State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 139 actively recruiting studies with Kansas sites out of 139 registered in total. The busiest research areas in Kansas are Obesity, Acute Myeloid Leukemia, Hypertension. Leading sponsors running trials in the state include University of Kansas Medical Center, SWOG Cancer Research Network, AstraZeneca. By stage, Kansas trials break down as Phase 1 (24), Phase 2 (45), Phase 3 (50), Phase 4 (4).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 139 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 139. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Obesity, Acute Myeloid Leukemia, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT07029581 Phase 2
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Condition
Lewy Body Dementia Psychosis
Enrollment
180 pts
Location
United States, Bulgaria, Czechia
Sponsor
ACADIA Pharmaceuticals Inc.
NCT06990867 Phase 2, Phase 3
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Condition
Acute Ischemic Stroke
Enrollment
740 pts
Location
United States, Belgium, Bulgaria
Sponsor
Corxel Pharmaceuticals
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
304 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
NCT07496567 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Brazil, Colombia
Sponsor
EyeBiotech Ltd.
NCT07333183 Phase 2
Recruiting
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Condition
Pulmonary Hypertension
Enrollment
20 pts
Location
United States
Sponsor
Pulmovant, Inc.
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT07353931 Phase 3
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthri...
Condition
Osteoarthritis
Enrollment
900 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT06022939 Phase 3
Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemothera...
Condition
AL Amyloidosis
Enrollment
338 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04939051 Phase 2
Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus
Condition
Barrett Esophagus
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05408845 Phase 2
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Ch...
Condition
Metastatic Salivary Gland Carcinoma
Enrollment
146 pts
Location
United States
Sponsor
NRG Oncology
NCT05248230 Phase 2
Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
Condition
Cystic Fibrosis Lung
Enrollment
30 pts
Location
United States
Sponsor
4D Molecular Therapeutics
NCT06343805 Phase 1
Recruiting
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-...
Condition
Primary Myelofibrosis
Enrollment
76 pts
Location
United States, France, Italy
Sponsor
Ajax Therapeutics, Inc.
NCT04561518 N/A
Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-M...
Condition
Transthyretin-Mediated Amyloidosis
Enrollment
1,500 pts
Location
United States, Brazil, Bulgaria
Sponsor
Alnylam Pharmaceuticals
NCT06891755 N/A
Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study...
Condition
COPD
Enrollment
250 pts
Location
United States, Austria, Netherlands
Sponsor
Apreo Health, Inc.
Page 6 of 6 — 139 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology